Crossbow Therapeutics
Cambridge
About Crossbow Therapeutics
Crossbow Therapeutics is a biotech company developing a new type of cancer treatment. They engineer antibodies to mimic T-cells, a natural part of the immune system, with the goal of improving the lives of cancer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $187.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2026)
- Website: crossbowtx.com
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/crossbow-therapeutics-77556 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.